Breast Augmentation: What the Surgery Involves, Who It Suits, and What to Expect

Considering breast augmentation abroad? This guide covers what the surgery involves, who is suitable, realistic recovery, genuine risks, and what to ask first.

Medically reviewed by Yamaç Çağlar (1 Oct, 2026)
A woman and a surgeon reviewing breast augmentation consultation documents in a softly lit clinical room

Breast augmentation — clinically termed augmentation mammoplasty — is one of the most frequently performed elective surgical procedures in the world, yet the detail of what it actually involves is often buried beneath vague reassurances. This guide covers the procedure itself, realistic candidacy criteria, what recovery genuinely looks like, and the trade-offs a person should weigh before committing.

What the surgery involves

Breast augmentation places a prosthetic implant — silicone gel-filled or saline-filled — behind the breast tissue, the chest muscle, or both, to increase volume or alter shape. The choice between gel and saline implants involves different trade-offs around feel, visible rippling, and the consequences of a rupture; this is discussed at the pre-operative assessment, not decided in advance.

The incision site varies. Common options include a cut in the inframammary fold (the crease beneath the breast), around the areola, or in the axilla (armpit). Each leaves a different scar location and carries slightly different implications for sensation and revision. A surgeon selects the approach based on implant type, size, patient anatomy, and the position of the implant relative to the muscle.

Placement is either subglandular (behind the breast tissue, in front of the muscle), submuscular (behind the pectoralis major), or a dual-plane position that combines elements of both. Submuscular placement generally provides more tissue coverage and is associated with lower rates of a complication called capsular contracture, but it can cause more discomfort in recovery and may produce visible implant movement when the chest muscle contracts. Subglandular placement tends to have a shorter recovery but less natural coverage in patients with little existing breast tissue.

The procedure is performed under general anaesthesia and typically takes between one and two hours. Most patients are discharged the same day or after a single overnight stay, depending on the facility's protocol and the individual's post-operative condition.

Who is and is not a suitable candidate

Candidacy is established through a surgical consultation, not through a checklist. That said, certain factors affect whether surgery is considered appropriate and safe.

  • Patients are typically in good general health, non-smokers or willing to stop smoking for a defined period before and after surgery, and at a stable weight.
  • Pregnancy or planned pregnancy in the near term is relevant — implants do not prevent breastfeeding in most cases, but they can complicate it, and pregnancy-related changes to the breast may alter the aesthetic outcome significantly.
  • Patients with uncontrolled diabetes, active autoimmune conditions, or bleeding disorders require more careful pre-operative evaluation before a surgeon can advise on suitability.
  • Very little natural breast tissue can limit implant coverage and raise the risk of visible rippling or an unnatural appearance, regardless of implant type.
  • Significant asymmetry, ptosis (breast droop), or skin laxity may require additional procedures — a lift, for instance — that change the scope and recovery of the surgery entirely.
  • Age is considered: most surgeons will not operate on patients under 18, and those under 22 may be advised to wait, as breast development may not be complete.

Patients who are seeking surgery to manage body dysmorphic disorder or significant psychological distress related to appearance are not considered suitable candidates for surgery. A pre-operative psychological assessment may be recommended in some cases.

Realistic recovery timeline

Recovery varies considerably between individuals and is influenced by implant placement, implant size, and a patient's general fitness and healing capacity. The following is a general pattern, not a guarantee.

In the first three to five days, most patients experience tightness, swelling, and soreness — more pronounced with submuscular placement, where the chest muscle has been elevated. Prescribed pain relief is usually sufficient; severe or increasing pain should be reported to the surgical team promptly as it can indicate a complication.

A supportive surgical bra is worn continuously for several weeks. Lifting, overhead movements, and strenuous physical activity are restricted for a minimum of four to six weeks. Most patients return to sedentary or desk-based work within one to two weeks, though this varies.

Swelling persists for several weeks, and the implants typically sit high on the chest initially before settling into their final position over two to four months. The appearance at six weeks is not the appearance at six months. Scars continue maturing for up to two years; their final quality depends on genetics, sun exposure, wound care, and other individual factors.

Risks and genuine trade-offs

Breast augmentation carries the general risks of any surgical procedure under anaesthesia — bleeding, infection, adverse reaction, and blood clots — as well as risks specific to this operation. Patients should receive a full informed-consent discussion before surgery; the following is not exhaustive.

  • Capsular contracture: scar tissue that forms around the implant can tighten, causing firmness, distortion, and discomfort. It occurs to varying degrees in a proportion of patients and may require revision surgery or implant removal.
  • Implant rupture or deflation: silicone gel ruptures are often silent and may go undetected without imaging; saline ruptures are immediately visible as the implant deflates. Both require replacement surgery.
  • Changes in nipple or breast sensation: reduced, increased, or altered sensation is common in the months following surgery. In most patients this improves, but permanent change is a recognised outcome.
  • Implant malposition: the implant can shift from its intended position over time, requiring surgical correction.
  • BIA-ALCL: breast implant-associated anaplastic large cell lymphoma is a rare form of lymphoma linked predominantly to textured-surface implants. It is not breast cancer; it arises in the scar tissue around the implant. Patients should discuss implant surface type and this risk explicitly with their surgeon.
  • Revision surgery: a meaningful proportion of patients undergo at least one additional procedure over the lifetime of their implants — whether for aesthetic refinement, a complication, or implant exchange. Implants are not lifetime devices.

Breast implants can also affect mammography. The imaging technique must be adapted to work around the implants, and some tissue may be obscured. This is important for anyone who is in, or approaching, an age group for routine breast cancer screening.

Questions worth asking before committing

  • What implant type, surface, and placement position is being recommended, and why specifically for your anatomy?
  • What incision approach is planned and where will the scar be?
  • What is the surgeon's policy and experience if revision is needed?
  • How will breast cancer screening work after surgery, and should you complete any baseline imaging beforehand?
  • What are the specific post-operative instructions, and what symptoms should prompt an urgent call to the clinical team?
  • What does the follow-up schedule look like, particularly if you are travelling from abroad?
  • Is a physical pre-operative consultation required, or will the full assessment happen remotely before you travel?

Travelling to Turkey for breast augmentation

Breast augmentation is commonly performed in Istanbul and Antalya, both of which have a substantial concentration of private hospitals and specialist plastic surgery clinics accustomed to treating international patients. Istanbul is the more common destination for those travelling from the UK and Western Europe, given direct flight connections from most major airports.

A typical stay for breast augmentation is five to seven days. This allows time for the pre-operative assessment and any pre-surgical tests on arrival, the procedure itself, an initial post-operative review, and a further review before departure. Staying for the full recommended period matters: leaving too early after surgery can mean missing early signs of a complication and limits the surgical team's ability to manage them.

For international patients arranging this type of surgery, accommodation and airport transfers are commonly coordinated as part of the overall care arrangement. Those reviewing plastic surgery packages should confirm precisely what is included — in particular, how many post-operative consultations are covered and what happens if additional care is needed after returning home.

Flying after breast augmentation requires careful timing. Most surgeons advise against long-haul or even medium-haul flights in the immediate post-operative period due to swelling, discomfort, and the elevated risk of deep vein thrombosis. This should be discussed explicitly when the travel itinerary is being planned, not after surgery.

Making an informed decision

Breast augmentation can produce significant and lasting changes to appearance, but it is not a risk-free procedure and the implants are not permanent devices. The most important work before surgery is the consultation — specifically, a thorough assessment of anatomy, an honest discussion of what is and is not achievable for that anatomy, and a clear account of every risk. Any surgeon or coordinator who is reluctant to spend time on the risk discussion is worth treating as a warning sign.